Table 1

Correlation between the clinicopathologic characteristics and expression of HDGF protein in liver cancer

Characteristics

n

HDGF (%)

P

High expression

Low expression


Group

Cancer tissue

137

73(53.3%)

64 (46.7%)

Normal tissue

49

16(32.7%)

33 (67.3%)

0.011

Gender

Male

87

51(58.6%)

36 (41.4%)

Female

50

22(44%)

28 (56%)

0.112

Age(y)

≥50

69

36 (52.2%)

33 (47.8%)

< 50

68

37(54.4%)

31(45.6%)

0.865

Smoking

Yes

47

24 (51.1%)

23 (48.9%)

No

90

49 (54.4%)

41 (45.6%)

0.722

Drinking wine

Yes

48

28(58.3%)

20(41.7%)

No

89

45(50.6%)

44(49.4%)

0.473

HBV Infection

Yes

103

54(52.4%)

49(47.6%)

No

34

19(55.9%)

15(44.1%)

0.843

T classification

T1-T2

98

42 (42.9%)

56(57.1%)

T3-T4

39

31 (79.5%)

8(20.5%)

0.000

N classification

N0-N1

64

22 (34.4%)

42 (65.6%)

N2-N3

73

51 (69.9%)

22 (30.1%)

0.000

Distant metastasis

Yes

33

22 (66.7%)

11 (33.3%)

No

104

51 (49%)

53 (51%)

0.109

Clinical stage

I~II

56

11(19.6%)

45 (80.4%)

III~IV

81

62 (76.5%)

19(23.5%)

0.000


Zhou et al. Diagnostic Pathology 2010 5:58   doi:10.1186/1746-1596-5-58

Open Data